Preclinical Studies Reveal MLN4924 Is a Promising New Retinoblastoma Therapy
Cell Death Discovery - United Kingdom
doi 10.1038/s41420-020-0237-8
Full Text
Open PDFAbstract
Available in full text
Date
January 20, 2020
Authors
Publisher
Springer Science and Business Media LLC